Physician

Daniel C Alter, MD

According to 2025 Medicare claims, Daniel Alter, MD (NPI: 1033184528) practices ophthalmology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is MIDWEST RETINA CONSULTANTS, S.C. (NPI: 1871545681; TIN: 36-3318169) and primary practice location at 60005-2042.

Alter's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,301 traditional Medicare patients, billed 62,236 HCPCS/CPT codes, and received $3,286,512 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 355 prescription claims across 138 beneficiaries totaling $17,200 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 21 records totaling $426. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,601,041 to $3,286,512. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $24,886 and ending at $17,200. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.3M2015 Medicare payment: $1,601,041 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,428,509 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,408,871 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,477,996 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,547,093 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,485,825 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,933,899 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,100,842 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,725,996 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,286,512 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,56121,436$1,601,041
20161,54522,106$1,428,509
20171,42922,527$1,408,871
20181,43822,117$1,477,996
20191,46021,587$1,547,093
20201,19815,224$1,485,825
20211,23516,318$1,933,899
20221,17416,687$2,100,842
20231,29739,683$2,725,996
20241,30162,236$3,286,512

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$19K$38K2015 Drug cost: $24,886 (USD; Tot_Drug_Cst)2016 Drug cost: $30,450 (USD; Tot_Drug_Cst)2017 Drug cost: $34,955 (USD; Tot_Drug_Cst)2018 Drug cost: $27,087 (USD; Tot_Drug_Cst)2019 Drug cost: $38,015 (USD; Tot_Drug_Cst)2020 Drug cost: $23,873 (USD; Tot_Drug_Cst)2021 Drug cost: $24,488 (USD; Tot_Drug_Cst)2022 Drug cost: $27,765 (USD; Tot_Drug_Cst)2023 Drug cost: $22,324 (USD; Tot_Drug_Cst)2024 Drug cost: $17,200 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015126290$24,886
2016130429$30,450
2017131441$34,955
2018120323$27,087
2019152384$38,015
2020105276$23,873
2021103285$24,488
2022102275$27,765
2023117307$22,324
2024138355$17,200

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye4512,396$100
92014Established patient complete exam of visual system1,1492,954$96
J9035Injection, bevacizumab, 10 mg2561,220$53
92134Imaging of retina1,1743,045$31
92202Extended exam of the back part of the eye with optic nerve drawing9432,079$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium38992$6,349
ProlensaBromfenac Sodium15393$5,351
Prednisolone AcetatePrednisolone Acetate1083,151$3,091
LatanoprostLatanoprost341,723$445
TobramycinTobramycin811,725$339

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.21$426Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Daniel C. Alter, MD?

Tedicare shows public-source Medicare data for Daniel C. Alter, MD (NPI 1033184528), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel C. Alter, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel C. Alter, MD?

Daniel C. Alter, MD is linked to MIDWEST RETINA CONSULTANTS, S.C. (billing NPI 1871545681) in the available physician profile data.

Does Daniel C. Alter, MD have Open Payments data?

Daniel C. Alter, MD has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.